本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ProKidney Corp.

2.70
+2.09345.18%
成交量:2.25亿
成交额:3.65亿
市值:3.50亿
市盈率:-4.53
高:2.94
开:1.27
低:1.02
收:0.6065
数据加载中...
2025/07/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

重要事件披露

Form 8-K - Current report
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/25

SEC问询函

Form CORRESP - Correspondence
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/22

重要事件披露

Form 8-K - Current report
2024/11/22

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]